Key result
Late-life depression is an underdiagnosed public health concern in older adults that requires careful assessment, management of modifiable risks, and evidence-based nonpharmacological treatments.
Why the study?
Assumptions that depression is part of normal aging and a lack of specific diagnostic criteria have left late-life depression underdiagnosed and untreated, creating serious public health concerns.
Late-life depression requires careful assessment and evidence-based treatments, with nonpharmacological approaches noted as more effective than pharmacological ones.
May support prioritizing nonpharmacological options in late-life depression; leaves open need for head-to-head trials.
As the U.S. population ages, the prevalence of late-life depression (LLD) increases. The general assumption that depression is part of normal aging and lack of diagnostic criteria specific to older adults resulted in this condition being underdiagnosed and untreated, leading to serious public health concerns, including high rates of suicide. Because of its complex etiologies, LLD requires careful assessment, especially in older adults from diverse ethnic/racial backgrounds. Suicide risk should be thoroughly assessed, including regular follow ups. Modifiable risks, such as cardiovascular conditions, should be addressed in middle-age populations to prevent LLD. Evidence-based treatment modalities include pharmacological (less effective) and more effective nonpharmacological (i.e., neuromodulation, psychotherapy) approaches. LLD has policy and research implications. Evidence exists of a new impetus to invest federal, state, and local funding for public health programs dedicated to improving the overall health of older adults. Research is needed to measure outcomes of these programs. [ Journal of Psychosocial Nursing and Mental Health Services, 61 (4), 8–11.]
No takes yet. Share an insight, caveat, or question.
Olimpia Paun (2023) conducted a review in Late-life depression. Late-life depression is an underdiagnosed public health concern in older adults that requires careful assessment, management of modifiable risks, and evidence-based nonpharmacological treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: